Reach Us +1-218-451-2974


Effect Of Ascorbic Acid On Mental Depression Drug Therapy: Clinical Study | 12463
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Effect of ascorbic acid on mental depression drug therapy: Clinical study

International Conference on Psychology, Autism and Alzheimers Disease

Suhera M. Aburawi

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.002

Depression disorders are very common in clinical practice. Ascorbic acid is a cofactor in synthesis of noradrenaline from dopamine and serotonin from tryptophan. The aim of this work was to study the efficacy of ascorbic acid on antidepressant therapy. Clinical prospective double blind study is planned to investigate the effect of ascorbic acid on the mental depression therapy and the possible therapeutic interaction with the pharmacotherapy of the disease. It was applied on twenty two outpatients who were diagnosed according to diagnostic and statistical manual of mental disorders 4th edition; patients should have a base line Hamilton rating scale for depression. The patients were randomly assigned to receive tablet of ascorbic acid with antidepressant (Group A) and tablet of placebo with antidepressants (Group B) for eight weeks. All patients submitted to laboratory investigation, the complete blood analysis, lipid profile, liver function test, renal function tests, serum electrolytes and complete urine analysis before and at the end of trial. Ascorbic acid levels in plasma were measured by HPLC. Ascorbic acid with antidepressants significantly decreased the total Hamilton depression rating scale and total questionnaire. Whole laboratory investigation were normal and within the normal value. The main overall finding from this study is that ascorbic acid was therapeutically benefited with antidepressant in the treatment of depression and predicts a good response in treated patients using combined ascorbic acid with antidepressants to be well tolerated and effective in depressive symptoms. Finally, this clinical trial results recommend combining ascorbic acid with antidepressants therapy. A large scale trial is advised.
Suhera M. Aburawi has completed her Ph.D. from Cairo University, Faculty of Pharmacy. Currently she is Professor in Pharmacology and Toxicology at University of Tripoli, Faculty of Pharmacy, Department of Pharmacology and Clinical Pharmacy. She has published 40 papers in journals and conferences.